Acoltremon

Uses your system voice; voice and rate in settings.

Snapshot

≈ 1 min read

Names in other languages

No names in other languages are held for this entry yet.

Article bodies are English and are not machine-translated. A name in another language is not a translation of the article.

Acoltremon sold under the brand name Tryptyr, is a medication used for the treatment of dry eye syndrome. Acoltremon is a transient receptor potential melastatin 8 (TRPM8) thermoreceptor agonist. It is used as an eye drop. The most common treatment-emergent adverse event experienced during the clinical studies was instillation site pain (burning or stinging) events. Acoltremon was approved for medical use in the United States in May 2025. The US Food and Drug Administration considers it to be a first-in-class medication.

Acoltremon sold under the brand name Tryptyr, is a medication used for the treatment of dry eye syndrome. Acoltremon is a transient receptor potential melastatin 8 (TRPM8) thermoreceptor agonist. It is used as an eye drop. The most common treatment-emergent adverse event experienced during the clinical studies was instillation site pain (burning or stinging) events. Acoltremon was approved for medical use in the United States in May 2025. The US Food and Drug Administration considers it to be a first-in-class medication.

Text derived from https://en.wikipedia.org/w/index.php?oldid=1365073895 under CC BY-SA 4.0; modifications have been made.

Sources cited in this revision

5 named source(s) extracted from the cited revision. A source with no author is shown by its publication; nothing is invented.